SCIENMAG: Medicine & Health

JANUARY 16, 2024

In early 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious and pathogenic virus, made its alarming debut and quickly spread worldwide, causing the novel coronavirus (COVID-19) pandemic that threatened human health and public safety.

Virus 93

Virus Hospitals 93

The Pharma Data

DECEMBER 21, 2020

The team at the Walter Reed Army Institute of Research is checking genetic sequences of the mutated virus variant posted online by British researchers, CNN reported. © 2020 HealthDay. Posted: December 2020. The new coronavirus variant in the UK that appears to spread faster is being studied by U.S. All rights reserved.

Vaccine 52

Vaccine Packaging Laboratories Virus 52

The Pharma Data

MARCH 13, 2022

People who gained immunity – either through vaccination or exposure – against the original strain of SARS-CoV-2, the virus that causes COVID-19, also are likely to have some protection against the pathogen’s omicron variant. population. The samples were stored after the researchers measured the T cell response.

Virus 52

Virus Immune Response Vaccine Research 52

The Pharma Data

AUGUST 3, 2021

The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2, the virus that causes COVID-19, in human cell cultures and in a mouse model, leading to much lower viral loads. The research team, including scientists from the U.S.

Virus 52

Virus Clinical Trials Drugs Laboratories 52

The Pharma Data

JANUARY 11, 2021

Food and Drug Administration said the test from California company Curative could produce false negatives, leading people with the virus to unknowingly spread it, the Associated Press reported. Last week, the U.S. The test is used by at least three of the largest U.S. cities, the AP reported.

Virus 52

Virus Vaccine FDA Research 52

PLOS: DNA Science

MAY 16, 2024

A Novel Virus Appears In retrospect, everything unfolded with astonishing speed. A few days after New Years, 2020, I heard BBC News report the first cases, in China. Whenever and wherever the virus emerged, CDC officially alerted clinicians to the new, deadly respiratory illness on January 8, 2020.

Virus 98

Virus DNA RNA Vaccine 98

Codon

AUGUST 26, 2024

When COVID-19 emerged in 2019, by contrast, mRNA vaccines developed by Pfizer and Moderna took just 326 days from the initial sequencing of the virus to gaining approval for emergency use. These drugs would be ideal tools to bridge the wait for a vaccine against a quickly-spreading virus.

RNA 97

RNA Virus DNA Vaccine 97

The Pharma Data

DECEMBER 31, 2020

Monthly News Roundup – December 2020. The messenger RNA (mRNA) vaccines encode a form of the spike (S) protein of SARS-CoV-2 virus. The vaccine teaches the cells to make a piece of the spike protein, which triggers an immune response to help prevent illness if later exposed to the virus. Posted: December 2020.

FDA Approval 52

FDA Approval Vaccine FDA Treatment 52

Drug Target Review

OCTOBER 26, 2023

1 Adeno-associated virus (AAV) vectors are the leading platform for in vivo gene delivery for the treatment of various human diseases. It has been well established that exposure to wild-type AAV results in priming of the immune system against the virus. Nature 578 , 229-236 (2020). Nature Reviews Genetics 21 , 255-272 (2020).

Engineering 105

Engineering Virus Therapies Immune Response 105

The Pharma Data

MARCH 24, 2021

Strong R&D commitment to developing therapeutics against SARS-CoV-2 virus. billion EUR in 2020 (18.9% Boehringer Ingelheim stepped up its investments in R&D significantly in 2020 in pursuit of innovative medicines and therapies for diseases for which no satisfactory treatments are available. of net sales). billion EUR).

Therapies 52

Therapies Disease Vaccine Small Molecule 52

The Pharma Data

DECEMBER 30, 2020

The year 2020 will certainly go down in history as the year of COVID-19. Gilead Sciences Makes Multiple Bets : When Gilead Sciences wasn’t working on remdesivir in COVID-19, the company seemed to be constantly flexing its M&A muscle over the course of 2020. It began in May with the $4.9

Science 52

Science Disease Pharmaceuticals Treatment 52

Drug Target Review

AUGUST 11, 2023

In a new development, a recent paper published in Biology Methods & Protocols by Oxford University Press has highlighted a promising avenue for enhancing vaccine efficacy against infectious pathogens like the COVID-19 virus. The role of extracellular vesicles in COVID-19 virus infection [Internet]. Available from: [link]

Vaccine 98

Vaccine Immune Response Bioinformatics Virus 98

The Pharma Data

MARCH 3, 2022

If approved by the FDA, this maternal immunization has the potential to be the first vaccine candidate to help protect infants in their vulnerable first months of life from disease caused by this highly-contagious virus. Burden of RSV RSV is a contagious virus and a common cause of respiratory illness. Pfizer Inc.

Virus 52

Virus Vaccine Clinical Trials Trials 52

Drug Target Review

JANUARY 26, 2024

These ACE2-coated particles could be tested as an anti-viral therapeutic, and as sensors for detecting virus particles. They also investigated the placement of ACE2 proteins onto nanoparticles for possible applications in rapid virus detection or infection treatment. 2020 March 30 [2024 January 22]; 581:215-220.

Production 114

Production DNA Virus Protein Expression 114

NIH Director's Blog: Drug Development

MARCH 18, 2021

With support from a 2020 NIH Director’s Pioneer Award, Veesler will study members of the order Chiroptera. These days, the Veesler lab has been hard at work to understand SARS-CoV-2 and the human immune response to the virus. 2020 Apr 16;181(2):281-292.e6. Or, more colloquially, bats. Veesler says bats are remarkable creatures.

Virus 52

Virus Immune Response Clinical Trials Treatment 52

The Pharma Data

DECEMBER 10, 2020

We know now that the viral RNA is found in stool and infectious virus as well. Therefore, Carlson said, “we advised no use of fecal donations from after Dec. 1, 2019, until effective screening methods are implemented.”. There were no methods for testing for COVID in stool,” he said. “We Infection in the GI tract is likely.”

FDA 52

FDA Laboratories RNA Virus 52

Broad Institute

JANUARY 30, 2024

He has also emerged in recent years as a skilled and relatable science communicator, renowned for his efforts at Broad and beyond during the COVID-19 pandemic to unpack the fast-moving research on the new virus in an accessible way and give practical advice about masking, vaccines, and other public health measures.

Hospitals 137

Hospitals Virus Medical Schools Science 137

The Pharma Data

DECEMBER 7, 2020

7, 2020 — Scientists say they may be getting closer to creating a universal flu vaccine. In an early-stage clinical trial with 65 volunteers in the United States, an experimental vaccine triggered strong immune responses to a wide range of flu virus strains and subtypes. © 2020 HealthDay. Posted: December 2020.

Vaccine 52

Vaccine Immune Response Virus Clinical Trials 52

The Pharma Data

MAY 6, 2021

This donation of the vaccine is another tool in our toolbox of measures to help make the Olympic and Paralympic Games Tokyo 2020 safe and secure for all participants and to show solidarity with our gracious Japanese hosts,” said IOC President Thomas Bach. “We This press release features multimedia. View the full release here: [link].

Vaccine 52

Vaccine Clinical Trials Licensing Licensing 52

The Pharma Data

DECEMBER 30, 2020

30, 2020 — The first recorded case of a faster-spreading variant of the new coronavirus has been detected in a 20-year-old man in Colorado, Gov. The young man carries a variant of the virus that is thought to be more contagious — but not more lethal — than variants previously circulating globally this year.

Virus 52

Virus Vaccine Research 52

The Pharma Data

DECEMBER 31, 2020

31, 2020 — Blood vessel damage and inflammation in the brains of deceased COVID-19 patients suggest the damage is not caused by the virus, but the body’s immune response to it. The researchers saw no signs of the virus in the tissue samples, which they said may mean that the damage was not caused by the virus itself.

Immune Response 52

Immune Response Virus Doctors Research 52

The Pharma Data

JANUARY 6, 2021

The announcement, following a $98 million IPO in October 2020, comes as the company advances several programs through its pipeline. In addition to its lead program, which began Phase I testing in 2020, the company expects to nominate three clinical candidates in 2021.

Virus 52

Virus FDA Approval Clinical Trials Trials 52

NIH Director's Blog: Drug Discovery

NOVEMBER 5, 2020

Because SARS-CoV-2 is so highly infectious, basic researchers without access to specially designed biosafety facilities may be limited in their ability to study the virus. While the quantum dots may bind and enter human cells just like the virus, they can’t cause an infection. 2020 Sep 22;14(9):12234-12247.

Research Laboratories 85

Research Laboratories Laboratories Science Drugs 85

The Pharma Data

DECEMBER 22, 2020

22, 2020 — A new study may prove reassuring for expectant moms: Pregnant women who are infected with COVID-19 during their third trimester appear unlikely to pass the infection to their fetuses. Researchers evaluated the levels of virus in respiratory, blood and placental tissue samples. ” © 2020 HealthDay.

Virus 52

Virus Vaccine Disease Hospitals 52

The Pharma Data

DECEMBER 22, 2020

22, 2020 — For Americans who are worried about the new coronavirus variant that is circulating in Britain, experts in the United States urge everyone to stay calm. “But again, the low mutation rate makes the adaptation of this virus to a vaccine less likely.” ” © 2020 HealthDay. TUESDAY, Dec.

Virus 52

Virus Vaccine Immune Response Treatment 52

The Pharma Data

DECEMBER 16, 2020

16, 2020 — A World Health Organization team of experts will examine samples and medical data from China to try to find out where the new coronavirus first made the leap from animals to people. © 2020 HealthDay. . © 2020 HealthDay. Posted: December 2020. WHO Team Seeks to Pinpoint Source of COVID-19. WEDNESDAY, Dec.

Virus 52

Virus Disease 52

New Drug Approvals

DECEMBER 26, 2022

1 heavy chain (1-456) (human vh (homo sapiens ighv1-69*01(ighd)-ighj4*01 (90.1%)) (8.8.19) (1-126) -homo sapiens ighg1*03 Immunoglobulin g1, anti-(human respiratory syncytial virus fusion protein)(human monoclonal med18897.gamma.1-chain), 2020) Dosage regimens for and compositions including anti-rsv antibodies. 2020/0347120 A1).

Virus 52

Virus Clinical Trials Trials Disease 52

The Pharma Data

DECEMBER 23, 2020

23, 2020 — A COVID-19 outbreak in Antarctica means that the new coronavirus is now spreading on every continent. Until then, Antarctica had been the only continent that was free of the virus, CNN reported. © 2020 HealthDay. Posted: December 2020. WEDNESDAY, Dec. CNN Article. All rights reserved. More News Resources.

Virus 52

Virus Research 52

The Pharma Data

DECEMBER 17, 2020

17, 2020 — As a rule, COVID-19 spreads rapidly in most groups, but new research suggests that schools and day care centers appear to be the exception. ” But for schools to be safe, they need a lot of help, support and equipment to keep the virus from spreading, Hobbs said. © 2020 HealthDay. . © 2020 HealthDay.

Virus 52

Virus Hospitals Disease Research 52

The Pharma Data

DECEMBER 15, 2020

15, 2020 — The U.S. Preventive Services Task Force (USPSTF) concludes that screening adults and adolescents at increased risk for hepatitis B virus (HBV) infection has moderate net benefit. © 2020 HealthDay. Posted: December 2020. Professional. USPSTF Recommends Hep B Screen for At-Risk Teens, Adults. TUESDAY, Dec.

Virus 52

Virus Therapies Trials Treatment 52

The Pharma Data

DECEMBER 21, 2020

21, 2020 — The new coronavirus variant in the United Kingdom that appears to spread faster is being studied by U.S. The team at the Walter Reed Army Institute of Research is checking genetic sequences of the mutated virus variant posted online by British researchers, CNN reported. © 2020 HealthDay. Posted: December 2020.

Research 52

Research Vaccine Virus Disease 52

The Pharma Data

DECEMBER 28, 2020

28, 2020 — Travelers flying to the United States from the United Kingdom will now need a negative COVID-19 test no more than 72 hours before leaving Britain, the U.S. The test is needed to guard against the spread of a new form of the virus found in the United Kingdom that may be 70 percent more contagious than other forms of COVID-19.

Virus 52

Virus Disease 52

The Pharma Data

DECEMBER 23, 2020

While the overall understanding of the condition is as novel as the virus that causes it, a recent survey from the U.K.’s This is proving very difficult, however, for the ever-expanding group of people dealing with the chronic and debilitating symptoms of what is commonly being called “Long Haul COVID” or “Long COVID.”.

Clinical Trials 52

Clinical Trials FDA Small Molecule Trials 52

Codon

AUGUST 27, 2024

While reading all the sequences present in a sample, researchers want to find any that are out of place, such as those that belong to a never-before-seen virus. The first cases of COVID emerged, undetected or under-addressed, several months before pandemic response measures were enacted in March 2020. We lost valuable time.

DNA 97

DNA Laboratories Hospitals Virus 97

The Pharma Data

JUNE 25, 2021

The outcome confirms that only one single case was attributable to the original SARS-CoV-2 virus. “In addition, the variant-rich environment underlines the importance of developing next-generation vaccines as new virus variants continue to emerge.” More than half of the cases (57%) were caused by Variants of Concern.

Vaccine 52

Vaccine Trials Immune Response Virus 52

The Pharma Data

FEBRUARY 1, 2021

HOUSTON, TX, February 01, 2021 /24-7PressRelease/ — It has been just over a year since the COVID-19 virus arrived in the United States, already claiming the lives of over 400,000 Americans. One recently introduced, promising COVID-19 treatment is produced from the antibodies in the plasma of recently recovered virus patients.

Treatment 52

Treatment Virus Hospitals Pharmaceutical Companies 52

The Pharma Data

MARCH 16, 2021

Today’s agreement with the Department of Health and Human Services (HHS) and the Department of Defense (DoD) builds on an agreement from October 2020 for the support of the late-stage development of AZD7442 and for the supply of an initial 100,000 doses of the LAAB combination. It included the option to acquire additional doses in 2021.

Treatment 52

Treatment Virus Trials Government 52